APA সাইটেশন

de Groot, J., Penas-Prado, M., Alfaro-Munoz, K., Hunter, K., Pei, B. L., O’Brien, B., . . . Heimberger, A. B. (2020). Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol.

শিকাগো স্টাইলে সাইটেশন

de Groot, John, et al. "Window-of-opportunity Clinical Trial of Pembrolizumab in Patients With Recurrent Glioblastoma Reveals Predominance of Immune-suppressive Macrophages." Neuro Oncol 2020.

এমএলএ সাইটেশন

de Groot, John, et al. "Window-of-opportunity Clinical Trial of Pembrolizumab in Patients With Recurrent Glioblastoma Reveals Predominance of Immune-suppressive Macrophages." Neuro Oncol 2020.